Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History SLP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics SLP

Max Ratio

1.01

5Y Dividend Growth

-25.00 %

Consecutive Years

5Y Average Payout Ratio

47.34 %
Forward Annual Dividend Yield 1.42 %
Consecutive Years 0
Forward Annual Dividend 0.24 USD
Consistent Years 11
Dividend CAGR 3Y -9.14 %
Continuous Dividends
Dividend CAGR 5Y -5.59 %
Payout Ratio TTM 11.54 %
Dividend CAGR 10Y -1.05 %
Ex Dividend Date 29.07.2024

Simulations Plus Inc

SLP
Current price
16.96 USD -0.62 USD (-3.53%)
Last closed 17.57 USD
ISIN US8292141053
Sector Healthcare
Industry Health Information Services
Exchange NASDAQ
Capitalization 354 156 736 USD
Yield for 12 month -59.59 %
1Y
3Y
5Y
10Y
15Y
SLP
21.11.2021 - 28.11.2021

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California. Address: 42505 Tenth Street West, Lancaster, CA, United States, 93534-7059

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

36.25 USD

P/E Ratio

48.81

Dividend Yield

1.38 %

Financials SLP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures SLP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+70 013 000 USD

Last Year

+59 577 000 USD

Current Quarter

+22 432 000 USD

Last Quarter

+18 924 000 USD

Current Year

+43 151 000 USD

Last Year

+47 947 000 USD

Current Quarter

+13 127 000 USD

Last Quarter

+10 218 000 USD
EBITDA 11 375 000 USD
Operating Margin TTM 11.64 %
Price to Earnings 48.81
Return On Assets TTM 1.98 %
PEG Ratio 9.77
Return On Equity TTM 3.96 %
Wall Street Target Price 36.25 USD
Revenue TTM 78 564 000 USD
Book Value 9.43 USD
Revenue Per Share TTM
Dividend Share 0.12 USD
Quarterly Revenue Growth YOY 22.50 %
Dividend Yield 1.38 %
Gross Profit TTM 43 427 000 USD
Earnings per share 0.36 USD
Diluted Eps TTM 0.36 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -25.00 %
Profit Margin 9.24 %

Stock Valuation SLP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 48.81
Forward PE 52.91
Enterprise Value Revenue 4.23
Price Sales TTM 4.51
Enterprise Value EBITDA 28.68
Price Book MRQ 1.86

Technical Indicators SLP

For 52 Weeks

16.72 USD 44.26 USD
50 Day MA 25.77 USD
Shares Short Prior Month 1 854 798
200 Day MA 29.24 USD
Short Ratio 4.50
Shares Short 1 560 059
Short Percent 16.08 %